GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » Shares Buyback Ratio %

MDXHF (Medx Health) Shares Buyback Ratio % : -33.79 (As of May. 06, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Medx Health Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Medx Health's current shares buyback ratio was -33.79%.

Medx Health Shares Buyback Ratio % Historical Data

The historical data trend for Medx Health's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health Shares Buyback Ratio % Chart

Medx Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.32 -22.52 -4.42 -0.05 -42.52

Medx Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.87 -29.72 - -2.86 -0.26

Medx Health Shares Buyback Ratio % Calculation

Medx Health's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(183.799 - 261.957) / 183.799
=-42.52%

Medx Health's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Sep. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(269.457 - 270.171) / 269.457
=-0.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medx Health Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Medx Health's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medx Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » Shares Buyback Ratio %
Comparable Companies
TSXV:VPT TSXV:NGMD TSXV:CNVI TSXV:ASG TSXV:THRM TSXV:FREQ TSXV:PINK TSXV:ZCT XCNQ:PMED XCNQ:MYTC ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
MDX:Canada
Address
1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Website
https://www.medxhealth.com
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.